计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| G287870-5mg |
5mg |
现货 ![]() |
| |
| G287870-10mg |
10mg |
现货 ![]() |
| |
| G287870-25mg |
25mg |
现货 ![]() |
| |
| G287870-50mg |
50mg |
现货 ![]() |
| |
| G287870-100mg |
100mg |
现货 ![]() |
|
| 别名 | 3-苯基-1H-苯并呋喃[3,2-c]吡唑 |
|---|---|
| 英文别名 | HSCI1_000176 | BRD-K16664969-001-01-7 | GTPL5982 | CCG-206757 | GTP 14564 | AKOS024456938 | HMS3413E13 | J-019773 | Q27077928 | 3-phenyl-2h-benzofuro[3,2-c]pyrazole | 1-Phenyl-3-H-8-oxa-2,3-diaza-cyclopenta[a]inden | SCHEMBL2550165 | 3-phenyl-1H-[1]benzof |
| 规格或纯度 | Moligand™, ≥99% |
| 英文名称 | GTP 14564 |
| 生化机理 | 强大的III类受体酪氨酸激酶选择性抑制剂(c-Fms,c-Kit,FLT3和ITD-FLT3的IC50值为0.3μM,PDGFRβ的IC50值为1μM)。对ERK1,ERK2,EGFR,MEK1,HER2,Src,Abl,PKC,PKA和Akt无活 性(IC50>10μM)。比BaF / wt-FLT3细胞更有效地抑制BaF / ITD-FLT3细胞中FL依赖性增殖;抗白血病。 |
| 储存温度 | 避光,-20°C储存 |
| 运输条件 | 超低温冰袋运输 |
| 作用类型 | 抑制剂 |
| 作用机制 | 集落刺激因子 1 受体抑制剂;FMS 相关受体酪氨酸激酶 3 抑制剂;KIT 原癌基因受体酪氨酸激酶抑制剂;血小板衍生生长因子受体 beta 抑制剂 |
| 产品介绍 |
Product description: A cell-permeable, reversible, ATP-competitive, and tricyclic, benzofurano-indazolo compound that acts as a potent and specific inhibitor of class III receptor tyrosine kinases (IC50 = 300 nM for c-fms, c-kit, wt-FLT3, and internal tandem duplication (ITD)-FLT3; 1 µM for PDGFRβ). Does not affect the activities of KDR, EGFR, HER2, Abl, Src, PKA, Akt, PKC, MEK, or ERK1/2 (IC50 >10 µM). Inhibits FLT-3 ligand-dependent growth of Ba/F3 cells expressing wild type FLT-3. Reported to be useful in differentiating signal transduction pathways activated by wt-FLT3 and ITD-FLT3 in Ba/F3 cells. A cell-permeable, reversible, and ATP-competitive tricyclic benzofurano-indazolo compound that acts as a potent and specific inhibitor of class III receptor tyrosine kinases (IC50 = 0.3 µM for c-fms, c-kit, wt-FLT3 and ITD-FLT3; 1.0 µM for PDGFRβ). Does not affect the activities of KDR, EGFR, HER2, Abl, Src, PKA, AKT, PKC, MEK, or ERK1/2 (IC50 ≥ 10 µM). Has been used successfully to differentiate between the signalling pathways activated by wt-FLT3 and ITD-FLT3 in Ba/F3 cells. |
| 纯度 | ≥99% |
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
| PubChem SID | 504762549 |
|---|---|
| 分子类型 | 小分子 |
| IIUPAC Name | 3-phenyl-1H-[1]benzofuro[3,2-c]pyrazole |
| INCHI | 1S/C15H10N2O/c1-2-6-10(7-3-1)13-15-14(17-16-13)11-8-4-5-9-12(11)18-15/h1-9H,(H,16,17) |
| InChi Key | DZQLVVLATXPWBK-UHFFFAOYSA-N |
| Smiles | C1=CC=C(C=C1)C2=NNC3=C2OC4=CC=CC=C43 |
| Isomeric SMILES | C1=CC=C(C=C1)C2=NNC3=C2OC4=CC=CC=C43 |
| 分子量 | 234.26 |
| Reaxy-Rn | 529164 |
| Reaxys-RN link address | https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=529164&ln= |
| 溶解性 | 溶于DMSO, 最高浓度 (mg/mL): 23.43, 最高浓度(mM): 100;溶于ethanol, 最高浓度 (mg/mL): 5.86, 最高浓度(mM): 25 |
|---|---|
| 敏感性 | 对光线敏感 |
| 分子量 | 234.250 g/mol |
| XLogP3 | 3.700 |
| 氢键供体数Hydrogen Bond Donor Count | 1 |
| 氢键受体数Hydrogen Bond Acceptor Count | 2 |
| 可旋转键计数Rotatable Bond Count | 1 |
| 精确质量Exact Mass | 234.079 Da |
| 单同位素质量Monoisotopic Mass | 234.079 Da |
| 拓扑极表面积Topological Polar Surface Area | 41.800 Ų |
| 重原子数Heavy Atom Count | 18 |
| 形式电荷Formal Charge | 0 |
| 复杂度Complexity | 303.000 |
| 同位素原子数Isotope Atom Count | 0 |
| 定义的原子立体中心计数Defined Atom Stereocenter Count | 0 |
| 未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
| 定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
| 未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
| 所有立体化学键的总数The total count of all stereochemical bonds | 0 |
| 共价键合单元计数Covalently-Bonded Unit Count | 1 |
| 预防措施声明 |
P264: 处理后要彻底洗手。 |
|---|
| 1. Murata K, Kumagai H, Kawashima T, Tamitsu K, Irie M, Nakajima H, Suzu S, Shibuya M, Kamihira S, Nosaka T et al.. (2003) Selective cytotoxic mechanism of GTP-14564, a novel tyrosine kinase inhibitor in leukemia cells expressing a constitutively active Fms-like tyrosine kinase 3 (FLT3).. J Biol Chem, 278 (35): (32892-8). [PMID:12815052] |